Lamictal (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neurons, reducing abnormal electrical activity and limiting the release of excitatory neurotransmitters such as glutamate. This stabilises neuronal membranes, which underlies its anticonvulsant and mood‑stabilising effects.

The dose of Lamictal is individualized by the prescribing clinician based on the patient’s condition, age, concomitant medications and renal or hepatic function. Only a qualified health professional should determine the appropriate dosing regimen.

Safety data for lamotrigine in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamictal.

To request Lamictal, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older sodium‑channel blockers such as carbamazepine, lamotrigine has a broader spectrum for seizure types and a lower risk of drug‑induced hyponatraemia. However, it carries a unique risk of severe skin reactions, especially when combined with valproate, which requires careful monitoring.

Lamictal tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and light, and ensure they are out of reach of children.

Lamictal is taken orally, usually with or without food, as a tablet. The exact administration schedule—once daily or divided doses—depends on the prescriber’s instructions and the patient’s therapeutic needs.

The most serious adverse events include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and anaphylaxis. Prompt medical attention is required if any signs of these reactions appear.

Lamictal is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with a history of severe skin reactions to antiepileptic drugs should avoid it, and it should be used with caution in those with significant renal or hepatic impairment.